Paper42777048PubMed
Computational design of optimized and preferentially paired human TCR constant regions for improved T cell function.
Radman M and 4 others. Sci Adv, 2026.
Cite this record
ConductScience Library. Computational design of optimized and preferentially paired human TCR constant regions for improved T cell function. Papers, record 42777048. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42777048
- Cell line
- A-375251 papers
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Computational design of optimized and preferentially paired human TCR constant regions for improved T cell function.
- Journal
- Sci Adv
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-09-25
Source PubMed
Connected records5
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Receptors, Antigen, T-Cell | Major topic |
| T-Lymphocytes | Major topic |
| Humans | |
| Animals | |
| Mice | |
| Lymphocyte Activation | |
| Xenograft Model Antitumor Assays | |
| CD4-Positive T-Lymphocytes | |
| Algorithms |
Source PubMed
References67
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27823582 | Domain-swapped T cell receptors improve the safety of TCR gene therapy. | Elife | 2016 | https://conductscience.org/library/papers/27823582 | PubMed |
| 2 | 20534461 | Mixed T cell receptor dimers harbor potentially harmful neoreactivity. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/20534461 | PubMed |
| 3 | 31500665 | A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function. | J Immunother Cancer | 2019 | https://conductscience.org/library/papers/31500665 | PubMed |
| 4 | 26389673 | Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes. | J Clin Invest | 2015 | https://conductscience.org/library/papers/26389673 | PubMed |
| 5 | 11753365 | Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRzeta /CD28 receptor. | Nat Biotechnol | 2002 | https://conductscience.org/library/papers/11753365 | PubMed |
| 6 | 28225754 | Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection. | Nature | 2017 | https://conductscience.org/library/papers/28225754 | PubMed |
| 7 | 27028870 | An optimized single chain TCR scaffold relying on the assembly with the native CD3-complex prevents residual mispairing with endogenous TCRs in human T-cells. | Oncotarget | 2016 | https://conductscience.org/library/papers/27028870 | PubMed |
| 8 | 31636040 | Simultaneous Deletion of Endogenous TCRαβ for TCR Gene Therapy Creates an Improved and Safe Cellular Therapeutic. | Mol Ther | 2020 | https://conductscience.org/library/papers/31636040 | PubMed |
| 9 | 22160697 | Structural and energetic evidence for highly peptide-specific tumor antigen targeting via allo-MHC restriction. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/22160697 | PubMed |
| 10 | 7925292 | Developmental regulation of alpha beta T cell antigen receptor expression results from differential stability of nascent TCR alpha proteins within the endoplasmic reticulum of immature and mature T cells. | EMBO J | 1994 | https://conductscience.org/library/papers/7925292 | PubMed |
| 11 | 38964783 | Genetically engineering glycolysis in T cells increases their antitumor function. | J Immunother Cancer | 2024 | https://conductscience.org/library/papers/38964783 | PubMed |
| 12 | 31442220 | Optimizing antibody affinity and stability by the automated design of the variable light-heavy chain interfaces. | PLoS Comput Biol | 2019 | https://conductscience.org/library/papers/31442220 | PubMed |
| 13 | 39133844 | Addressing epistasis in the design of protein function. | Proc Natl Acad Sci U S A | 2024 | https://conductscience.org/library/papers/39133844 | PubMed |
| 14 | 33558725 | TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers. | Nat Med | 2021 | https://conductscience.org/library/papers/33558725 | PubMed |
| 15 | 35165867 | Adoptive T-cell Immunotherapy: Perfecting Self-Defenses. | Exp Suppl | 2022 | https://conductscience.org/library/papers/35165867 | PubMed |
| 16 | 40097658 | Design of sensitive monospecific and bispecific synthetic chimeric T cell receptors for cancer therapy. | Nat Cancer | 2025 | https://conductscience.org/library/papers/40097658 | PubMed |
| 17 | 10981663 | Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR. | Gene Ther | 2000 | https://conductscience.org/library/papers/10981663 | PubMed |
| 18 | 17440104 | Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond. | Cancer Res | 2007 | https://conductscience.org/library/papers/17440104 | PubMed |
| 19 | 34878825 | Combining a CAR and a chimeric costimulatory receptor enhances T cell sensitivity to low antigen density and promotes persistence. | Sci Transl Med | 2021 | https://conductscience.org/library/papers/34878825 | PubMed |
| 20 | 31182835 | Orthotopic replacement of T-cell receptor α- and β-chains with preservation of near-physiological T-cell function. | Nat Biomed Eng | 2019 | https://conductscience.org/library/papers/31182835 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| TRBV20OR9-2 | 6962 | PubTator's text mining | https://conductscience.org/library/genes/6962 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42777048
GET https://conductscience.org/api/papers/v1/42777048/references?page=2